All Practice Exams

Free Practice Questions for Iraqi Board Internal Medicine

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card

Loading practice questions...

Exam Review

Key Facts: Iraqi Board Internal Medicine Exam

IBMS / MOHESR

Governing Body & Ministry

Iraqi Board for Medical Specializations

4 Years

Residency Training Duration

IBMS Curriculum 2024-2025

70% / 60%+70%

Published Pass Marks (Preliminary / Final Written)

Scientific Council of Internal Medicine curriculum

110 MCQs

Practice Bank Study Items

OpenExamPrep

The Iraqi Board of Internal Medicine (FIBMS) is a 4-year postgraduate residency credential administered by the Scientific Board of Internal Medicine under IBMS and MOHESR. Assessment encompasses the Preliminary Written Exam (end of Year 1, 70% pass mark), Intermediate Clinical Skills OSCE (60% pass mark), a defended research dissertation, and the Final Examination (end of Year 4, featuring two 80-MCQ papers requiring 60% per paper and 70% composite average, followed by a 5-station clinical OSCE and oral viva). This independent 110-question practice bank covers theoretical written knowledge for Part 1 and Part 2; it is not a clinical OSCE simulation or a substitute for accredited residency training.

Sample Iraqi Board Internal Medicine Practice Questions

Try these sample questions to review concepts for the Iraqi Board Internal Medicine exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 110+ question experience with AI tutoring.

1A 58-year-old man presents with acute crushing retrosternal chest pain radiating to his left arm of 2 hours' duration. ECG shows 3-mm ST-segment elevation in leads V1–V4 with reciprocal depressions in leads II, III, and aVF. Heart rate is 88 bpm and blood pressure is 135/85 mmHg. The nearest cardiac catheterization facility is 25 minutes away. In addition to dual antiplatelet therapy and anticoagulation, which of the following is the most appropriate next step in management?
A.Immediate intravenous thrombolytic therapy with tenecteplase
B.Immediate transfer for primary percutaneous coronary intervention
C.Intravenous unfractionated heparin infusion and discharge to ward
D.Urgent coronary artery bypass graft surgery
Explanation: Primary percutaneous coronary intervention (PCI) is the preferred reperfusion strategy for acute ST-elevation myocardial infarction (STEMI) when it can be performed within 120 minutes of diagnosis. Because transfer to the cardiac catheterization facility takes only 25 minutes, primary PCI is well within the recommended time window and is superior to fibrinolysis in reducing reinfarction and mortality.
2A 64-year-old woman with chronic heart failure and an ejection fraction of 30% presents for outpatient follow-up. She reports persistent dyspnea on mild exertion (NYHA Class III). Her medications include sacubitril/valsartan 97/103 mg twice daily, carvedilol 25 mg twice daily, and spironolactone 25 mg daily. Blood pressure is 118/76 mmHg, heart rate is 68 bpm, and serum potassium is 4.6 mEq/L with eGFR of 52 mL/min/1.73 m². Which medication should be added next to reduce heart failure hospitalization and mortality?
A.Dapagliflozin
B.Digoxin
C.Diltiazem
D.Amlodipine
Explanation: According to international guidelines on heart failure with reduced ejection fraction (HFrEF), guideline-directed medical therapy (GDMT) consists of four foundational pillars: an ARNI/ACEi, an evidence-based beta-blocker, a mineralocorticoid receptor antagonist (MRA), and an SGLT2 inhibitor (dapagliflozin or empagliflozin). Adding dapagliflozin significantly reduces cardiovascular mortality and heart failure hospitalizations regardless of diabetic status.
3A 42-year-old man presents with sudden palpitations and lightheadedness. Blood pressure is 120/78 mmHg and heart rate is 185 bpm. The 12-lead ECG reveals a narrow-complex regular tachycardia with no visible P waves. Vagal maneuvers are performed without effect. Which of the following is the first-line pharmacologic agent for acute termination?
A.Intravenous adenosine
B.Intravenous amiodarone
C.Intravenous digoxin
D.Intravenous atropine
Explanation: Intravenous adenosine (6 mg rapid push, followed if necessary by 12 mg) is the drug of choice for acute conversion of stable regular narrow-complex paroxysmal supraventricular tachycardia (AVNRT or AVRT). It acts by transiently blocking AV nodal conduction, terminating the reentry circuit with an extremely short half-life.
4A 72-year-old man presents with progressive exertional dyspnea, angina, and a syncopal episode while climbing stairs. Physical examination reveals a harsh, late-peaking systolic ejection murmur loudest at the right upper sternal border that radiates to the carotids, accompanied by a delayed and diminished carotid pulse (pulsus parvus et tardus). Echocardiography confirms a peak aortic velocity of 4.3 m/s and mean gradient of 48 mmHg. What is the definitive management?
A.Aortic valve replacement
B.High-dose intravenous loop diuretics
C.Intensive vasodilator therapy with nitroprusside
D.Long-term oral beta-blocker monotherapy
Explanation: The patient has symptomatic severe aortic stenosis, demonstrated by the classic triad of angina, syncope, and heart failure symptoms along with peak velocity >4 m/s and mean gradient >40 mmHg. Symptomatic severe aortic stenosis carries a grim prognosis without intervention, and definitive management is aortic valve replacement (surgical SAVR or transcatheter TAVR).
5A 35-year-old woman with a history of rheumatic mitral stenosis presents with rapid palpitations and mild dyspnea. ECG demonstrates atrial fibrillation with a ventricular rate of 135 bpm. Echocardiography shows a mitral valve area of 1.2 cm² and left atrial diameter of 48 mm. Her CHA2DS2-VASc score is 1. Which anticoagulation strategy is indicated?
A.Warfarin with target INR 2.0–3.0
B.Apixaban 5 mg twice daily
C.Aspirin 81 mg daily monotherapy
D.No anticoagulation because CHA2DS2-VASc is 1
Explanation: Atrial fibrillation in the presence of moderate-to-severe rheumatic mitral stenosis or a mechanical prosthetic heart valve is classified as 'valvular atrial fibrillation'. Direct oral anticoagulants (DOACs) are not approved for moderate-to-severe rheumatic mitral stenosis; vitamin K antagonists (warfarin) with an INR goal of 2.0–3.0 remain mandatory, regardless of the CHA2DS2-VASc score.
6A 68-year-old male with a 45-pack-year smoking history presents with worsening dyspnea, increased sputum volume, and sputum purulence for 3 days. On examination, oxygen saturation is 87% on room air, respiratory rate is 26 breaths/min, and diffuse expiratory wheezing is audible. Arterial blood gas shows pH 7.32, PaCO2 56 mmHg, and PaO2 54 mmHg. In addition to controlled oxygen, nebulized bronchodilators, and systemic corticosteroids, which antibiotic is most appropriate?
A.Amoxicillin-clavulanate
B.Oral ciprofloxacin
C.Intravenous vancomycin
D.Oral metronidazole
Explanation: This patient meets Anthonisen criteria for a Type 1 severe acute exacerbation of COPD (all three cardinal symptoms: increased dyspnea, sputum volume, and sputum purulence). The common bacterial pathogens are Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. An aminopenicillin with beta-lactamase inhibitor (amoxicillin-clavulanate) or a macrolide is first-line empirical coverage.
7A 52-year-old woman presents with pleuritic chest pain and acute shortness of breath 10 days following an elective total hip replacement. On examination, heart rate is 112 bpm, blood pressure is 124/82 mmHg, respiratory rate is 24 breaths/min, and oxygen saturation is 91% on room air. D-dimer is markedly elevated. What is the definitive imaging investigation of choice to confirm the suspected diagnosis?
A.CT pulmonary angiography
B.Transthoracic echocardiography
C.Standard posteroanterior chest radiography
D.Ventilation-perfusion scan
Explanation: CT pulmonary angiography (CTPA) is the gold standard diagnostic modality for acute pulmonary embolism in hemodynamically stable patients with high clinical probability. It provides direct visualization of intraluminal filling defects in the pulmonary arterial tree with high sensitivity and specificity.
8A 62-year-old man presents with progressive non-productive cough and exertional dyspnea over the past 9 months. Physical examination reveals digital clubbing and bilateral fine late-inspiratory 'Velcro-like' crackles at both lung bases. High-resolution computed tomography (HRCT) shows subpleural, basal-predominant reticular opacities with honeycombing and traction bronchiectasis, without extensive ground-glass opacities. Pulmonary function testing shows a restrictive pattern with reduced DLCO. What is the most likely diagnosis?
A.Idiopathic pulmonary fibrosis
B.Hypersensitivity pneumonitis
C.Pulmonary sarcoidosis
D.Pneumocystis jirovecii pneumonia
Explanation: The clinical presentation of progressive exertional dyspnea, clubbing, and end-inspiratory Velcro crackles combined with an HRCT showing a definite usual interstitial pneumonia (UIP) pattern (basal and subpleural reticulation, honeycombing, traction bronchiectasis, minimal ground-glass) in the absence of an identifiable secondary cause is diagnostic of idiopathic pulmonary fibrosis (IPF).
9A 28-year-old woman with a history of persistent asthma presents to the emergency department with acute breathlessness and chest tightness. Despite using her salbutamol inhaler repeatedly at home, she speaks only in short words, has a respiratory rate of 32 breaths/min, heart rate of 128 bpm, and pulsed oxygen saturation of 90% on ambient air. Auscultation reveals a quiet chest with minimal air entry. Arterial blood gas shows pH 7.38, PaCO2 42 mmHg, and PaO2 58 mmHg. How should this PaCO2 value be interpreted?
A.An ominous sign indicating impending respiratory muscle exhaustion
B.A reassuring sign indicating adequate alveolar ventilation
C.Normal gas exchange typical of mild acute asthma
D.Primary metabolic compensation for metabolic acidosis
Explanation: During an acute asthma exacerbation, intense hyperventilation typically drives PaCO2 down (respiratory alkalosis). A 'normal' PaCO2 (40–42 mmHg) or elevated PaCO2 in a severely distressed, tachypneic asthmatic represents inadequate ventilation and impending respiratory muscle exhaustion, which is a life-threatening sign requiring immediate aggressive escalation.
10A 29-year-old woman with long-standing asthma has become increasingly steroid-dependent, coughing up thick brown mucus plugs. Chest imaging shows fleeting infiltrates and central bronchiectasis with normal distal airways. Total IgE is 2,400 IU/mL, peripheral eosinophils are 1.4 x 10^9/L, and both Aspergillus-specific IgE and IgG are raised. What is the diagnosis and the mainstay of treatment?
A.Allergic bronchopulmonary aspergillosis; systemic corticosteroids, with itraconazole added as a steroid-sparing agent
B.Invasive pulmonary aspergillosis; intravenous voriconazole and reversal of immunosuppression
C.Aspergilloma in a pre-existing cavity; surgical resection or bronchial artery embolisation
D.Chronic eosinophilic pneumonia; long-term inhaled corticosteroid monotherapy
Explanation: Allergic bronchopulmonary aspergillosis is a hypersensitivity reaction to Aspergillus fumigatus colonising the airways of patients with asthma or cystic fibrosis, not an invasive infection. The characteristic combination is deteriorating, steroid-dependent asthma, expectoration of brown mucus plugs, fleeting radiographic infiltrates, and central bronchiectasis that spares the distal airways, supported by immediate skin reactivity or specific IgE to Aspergillus, a markedly raised total IgE (conventionally above 1,000 IU/mL), raised Aspergillus-specific IgG or precipitins, and peripheral eosinophilia. Treatment is directed at the immune response: systemic corticosteroids are the mainstay, with itraconazole used to reduce the fungal antigen burden and allow steroid reduction. Total IgE is followed serially as a marker of disease activity, and recognising the condition early matters because untreated inflammation progresses to fixed bronchiectasis and fibrosis.

About the Iraqi Board Internal Medicine Exam

The Fellowship of the Iraqi Board for Medical Specializations in Internal Medicine (F.I.B.M.S.) is the pinnacle postgraduate clinical qualification for internists in Iraq, awarded by the Iraqi Board for Medical Specializations (IBMS) under the Ministry of Higher Education and Scientific Research (MOHESR). The rigorous 4-year residency program trains physicians across university teaching hospitals (including Medical City Baghdad, Al-Yarmouk, Al-Kindi, Al-Imamain Al-Kadhimiyan, Marjan in Babylon, Al-Basra, and Erbil) in inpatient wards, intensive care, coronary care, and specialized medical rotations. Important disclosure: The complete FIBMS qualification requires accredited clinical residency training, satisfactory procedural documentation, an approved and defended scientific research dissertation, and a structured clinical OSCE with oral viva, none of which can be replaced by multiple-choice practice. This 110-question multiple-choice practice bank is an independent English-language educational resource designed to support theoretical knowledge reinforcement and clinical reasoning for the Part 1 (Preliminary) and Part 2 (Final Written) examinations. It is not an official IBMS examination, does not provide OSCE stations, and is not an endorsement from or affiliated with IBMS or MOHESR.

Exam sponsor: Scientific Board of Internal Medicine, Iraqi Board for Medical Specializations (المجلس العراقي للاختصاصات الطبية — المجلس العلمي لاختصاص الطب الباطني). The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Assessment

The Iraqi Board in Internal Medicine follows a four-year structured postgraduate residency governed by the Scientific Board of Internal Medicine under the Iraqi Board for Medical Specializations (IBMS) and the Ministry of Higher Education and Scientific Research (MOHESR). The assessment structure includes four primary milestones: 1) The Preliminary Written Examination (held in October and April at the end of Year 1), featuring multiple-choice questions assessing basic medical sciences applied to clinical medicine (pathophysiology, clinical pharmacology, laboratory and imaging interpretation; passing score 70%; maximum 4 attempts allowed before progressing to Year 3). 2) The Intermediate Clinical Skills Examination, conducted in OSCE format at accredited training centers (passing score 60%; mandatory prior to Year 4 and prior to the final written exam). 3) The Scientific Research Project, formulated in Year 3 and defended before a scientific panel prior to the final examination. 4) The Final Board Examination at the end of Year 4, which comprises a written examination of two papers (each containing 80 MCQs, optical mark read; minimal pass level 60% per paper, with an aggregate composite mean of at least 70% to pass) followed by a 5-station clinical OSCE (2 focused history, 2 focused clinical exam, 1 communication skills; minimal passing score 70% total with at least 60% in each station) and oral case viva discussions.

Time Limit

1.5 to 2 hours per written paper (two papers per final written examination diet)

Passing Score

Preliminary written MCQ examination: 70%. Final written examination: at least 60% in each of the two papers and at least 70% combined. Clinical skills OSCE (required before Year 4): 60%. Final clinical OSCE of at least five stations: 70%.

Exam / Certification Fees

Prescribed by Iraqi Board for Medical Specializations / MOHESR regulatory bylaws

Exam sponsor website

Reported exam pass rate: 70% (Preliminary) / 60% per paper and 70% combined (Final). The Preliminary written multiple-choice examination has a pass mark of 70% and must be passed before progression to Year 3. The Final written examination requires at least 60% in each of the two papers and at least 70% combined. The clinical skills OSCE, which is mandatory before Year 4, requires 60%, and the final clinical OSCE of at least five stations requires 70%. This describes exam candidates, not OpenExamPrep users or results from using our resources. Exam sponsor website

Fees, eligibility, and exam policies can change. Confirm them with the exam sponsor before applying or paying.

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

22%

Cardiology & Respiratory Medicine

Coronary artery disease, acute coronary syndromes, heart failure guidelines, arrhythmias, valvular heart disease, hypertension, asthma, COPD exacerbations, interstitial lung diseases, pulmonary thromboembolism, and acute respiratory failure.

20%

Gastroenterology, Hepatology & Nutrition

Gastroesophageal reflux disease, peptic ulcer disease, inflammatory bowel disease, cirrhosis, portal hypertension, ascites and spontaneous bacterial peritonitis, acute and chronic viral hepatitis B and C, acute pancreatitis, and clinical nutrition.

20%

Nephrology, Endocrinology & Metabolism

Acute kidney injury, chronic kidney disease staging and complications, glomerulonephritis, acid-base and electrolyte disturbances, type 1 and type 2 diabetes mellitus, diabetic ketoacidosis, thyroid dysfunction, adrenal insufficiency, Cushing syndrome, and calcium disorders.

20%

Infectious Diseases, Endemic Pathogens & Hematology/Oncology

Regional endemic pathogens (brucellosis, visceral and cutaneous leishmaniasis, typhoid fever, Crimean-Congo hemorrhagic fever, tuberculosis), microcytic and macrocytic anemias, hemoglobinopathies (thalassemia major and intermedia), acute and chronic leukemias, lymphomas, and multiple myeloma.

18%

Rheumatology, Neurology & Clinical Immunology

Systemic lupus erythematosus, rheumatoid arthritis, seronegative spondyloarthropathies, systemic vasculitides, acute ischemic and hemorrhagic stroke, epilepsy and status epilepticus, bacterial and viral meningoencephalitis, and neuromuscular junction disorders.

Preparing for the Iraqi Board Internal Medicine Exam

What You Need to Know

  • Passing score: Preliminary written MCQ examination: 70%. Final written examination: at least 60% in each of the two papers and at least 70% combined. Clinical skills OSCE (required before Year 4): 60%. Final clinical OSCE of at least five stations: 70%.
  • Assessment: The Iraqi Board in Internal Medicine follows a four-year structured postgraduate residency governed by the Scientific Board of Internal Medicine under the Iraqi Board for Medical Specializations (IBMS) and the Ministry of Higher Education and Scientific Research (MOHESR). The assessment structure includes four primary milestones: 1) The Preliminary Written Examination (held in October and April at the end of Year 1), featuring multiple-choice questions assessing basic medical sciences applied to clinical medicine (pathophysiology, clinical pharmacology, laboratory and imaging interpretation; passing score 70%; maximum 4 attempts allowed before progressing to Year 3). 2) The Intermediate Clinical Skills Examination, conducted in OSCE format at accredited training centers (passing score 60%; mandatory prior to Year 4 and prior to the final written exam). 3) The Scientific Research Project, formulated in Year 3 and defended before a scientific panel prior to the final examination. 4) The Final Board Examination at the end of Year 4, which comprises a written examination of two papers (each containing 80 MCQs, optical mark read; minimal pass level 60% per paper, with an aggregate composite mean of at least 70% to pass) followed by a 5-station clinical OSCE (2 focused history, 2 focused clinical exam, 1 communication skills; minimal passing score 70% total with at least 60% in each station) and oral case viva discussions.
  • Time limit: 1.5 to 2 hours per written paper (two papers per final written examination diet)
  • Exam / certification fees: Prescribed by Iraqi Board for Medical Specializations / MOHESR regulatory bylaws Official sources

Using Our Practice Resources

  • Work through all 110 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Iraqi Board Internal Medicine: Suggested Study Strategy

1Master high-yield clinical guidelines across cardiology and pulmonology: emphasize ESC/AHA guidelines for STEMI/NSTEMI management, guideline-directed medical therapy (GDMT) in heart failure with reduced ejection fraction (HFrEF), GOLD guidelines for COPD exacerbations, and GINA stepwise asthma therapy.
2Understand diagnostic and management algorithms for endemic diseases in Iraq: prioritize diagnosis and antibiotic regimens for brucellosis (doxycycline + rifampicin or aminoglycosides), leishmaniasis (sodium stibogluconate / liposomal amphotericin B), Crimean-Congo hemorrhagic fever protocols, and extrapulmonary tuberculosis.
3Review acid-base, electrolyte, and renal emergencies thoroughly: calculate anion gap, delta-delta ratios, understand acute kidney injury KDIGO staging, indications for emergent dialysis, and management of severe hyperkalemia and hyponatremia.
4Focus on endocrinology and hematology bread-and-butter topics: master diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) fluid and insulin protocols, workup of thyroid nodules, adrenal crisis, workup of microcytic hypochromic anemias including beta-thalassemia trait vs. iron deficiency, and acute leukemia emergency presentations.
5Consolidate neurology and rheumatology emergency presentations: know acute stroke thrombolysis and thrombectomy inclusion/exclusion windows, status epilepticus escalations, CSF analysis in meningoencephalitis, and lupus nephritis classification and induction therapies.

Frequently Asked Questions

What is the governing authority and credential awarded by the Iraqi Board in Internal Medicine?

The program is administered by the Scientific Board of Internal Medicine under the Iraqi Board for Medical Specializations (IBMS / المجلس العراقي للاختصاصات الطبية), which operates under the Ministry of Higher Education and Scientific Research (MOHESR). Successful candidates are awarded the Fellowship of the Iraqi Board for Medical Specializations (F.I.B.M.S.) in Internal Medicine, the premier professional medical qualification in Iraq.

What is the examination structure of the Iraqi Board in Internal Medicine?

The curriculum features four structured evaluation components: 1) The Preliminary Written Examination at the end of Year 1 (MCQ format covering basic medical sciences applied to clinical practice; 70% passing score; maximum 4 attempts). 2) The Intermediate Clinical Skills Examination (OSCE format; 60% passing score; required before Year 4). 3) A defended scientific research dissertation prepared during Year 3 and Year 4. 4) The Final Board Examination at the end of Year 4, consisting of two written MCQ papers (80 questions each, requiring 60% minimum per paper and 70% composite average) and a 5-station clinical OSCE (covering focused history, clinical examination, and communication skills; requiring 70% overall with no station below 60%) alongside an oral viva.

What are the passing scores and retake policies for the written papers?

The Preliminary written examination has a pass mark of 70% and must be passed before progression to Year 3, with up to four attempts permitted and sittings in the first week of October and in April. The Final written examination requires at least 60% in each of the two papers and at least 70% combined, also with up to four attempts. The clinical skills OSCE required before Year 4 has a pass mark of 60%, and the final clinical OSCE of at least five stations requires 70%. A candidate who passes the written examination but fails the clinical examination four times must retake the written papers if more than three years have elapsed.

In what language are the Iraqi Board internal medicine examinations conducted?

The Iraqi Board for Medical Specializations publishes this council's curriculum, syllabus and reference list in English, and English-language proficiency appears among the admission requirements set by the Ministry. The council's published curriculum does not, however, contain any statement of the language in which the examination papers themselves are set, so no language of assessment is asserted here. This site is an independent English-language study resource and is not affiliated with, endorsed by, or connected to the Iraqi Board for Medical Specializations; candidates should confirm the language of their sitting directly with their Scientific Council.

Does this 110-question practice bank simulate the clinical OSCE or replace residency training?

No. The Iraqi Board qualification is an intensive 4-year clinical hospital residency demanding extensive patient care, ward management, procedural competencies, research defense, and a multi-station clinical OSCE with oral case discussions. This independent 110-question multiple-choice practice bank is strictly an educational study resource designed to help residents review theoretical medical knowledge and diagnostic reasoning for the Part 1 and Part 2 written examinations; it is not an OSCE simulation or a substitute for formal accredited clinical residency training.